CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
38.79
2.48 (6.83%)
At close: May 16, 2025, 3:59 PM
38.51
-0.73%
After-hours: May 16, 2025, 05:57 PM EDT
CRISPR Therapeutics Revenue
CRISPR Therapeutics reported an annual revenue of $35M, reflecting a -90.57% growth. For the quarter ending March 31, 2025, CRISPR Therapeutics generated $0 in revenue.
Revenue (ttm)
$35M
Revenue Growth
-90.57%
Price / Sales Ratio
94.87
Revenue / Employee
$89.06K
Employees
393
Market Cap
3.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|